These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 6722781

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Development and biologic properties of malignant cell sublines and clones of a spontaneously metastasizing rat mammary adenocarcinoma.
    Neri A, Welch D, Kawaguchi T, Nicolson GL.
    J Natl Cancer Inst; 1982 Mar; 68(3):507-17. PubMed ID: 6950180
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Heterogeneity in the sensitivities of the 13762NF rat mammary adenocarcinoma cell clones to cytolysis mediated by extra- and intratumoral macrophages.
    North SM, Nicolson GL.
    Cancer Res; 1985 Apr; 45(4):1453-8. PubMed ID: 3978611
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A 6-thioguanine-resistant variant of the 13762 cell line which is no longer tumorigenic or metastatic.
    Ramshaw IA, Carlsen SA, Hoon D, Warrington RC.
    Int J Cancer; 1982 Nov 15; 30(5):601-7. PubMed ID: 6891375
    [Abstract] [Full Text] [Related]

  • 10. Cell surface properties of spontaneously metastasizing rat mammary adenocarcinoma cell clones.
    Steck PA, Nicolson GL.
    Transplant Proc; 1984 Apr 15; 16(2):355-60. PubMed ID: 6719540
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Immune response to a mammary adenocarcinoma. V. Sera from tumor-bearing rats contain multiple factors blocking cell-mediated cytotoxicity.
    Huber SA, Lucas ZJ.
    J Immunol; 1978 Dec 15; 121(6):2485-9. PubMed ID: 722081
    [Abstract] [Full Text] [Related]

  • 13. Enhanced plasminogen activator production by highly metastatic variant cell lines of a rat mammary adenocarcinoma.
    Ramshaw IA, Badenoch-Jones P, Grant A, Maxted M, Claudianos C.
    Invasion Metastasis; 1986 Dec 15; 6(3):133-44. PubMed ID: 3733365
    [Abstract] [Full Text] [Related]

  • 14. Differential release of active proteinase inhibitors by two rat mammary adenocarcinoma variants possessing different metastatic potentials.
    Neri A, Bohoslawec O, Anderson TD, Tokes ZA.
    Cancer Res; 1991 Feb 15; 51(4):1318-25. PubMed ID: 1997170
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Organization of cytoskeletal structures in 13762NF rat mammary adenocarcinoma cell lines and clones of different metastatic potentials.
    Lichtner RB, Nicolson GL.
    Invasion Metastasis; 1987 Feb 15; 7(2):73-82. PubMed ID: 3583622
    [Abstract] [Full Text] [Related]

  • 17. Serum and plasma M(r) 92,000 progelatinase levels correlate with spontaneous metastasis of rat 13762NF mammary adenocarcinoma.
    Nakajima M, Welch DR, Wynn DM, Tsuruo T, Nicolson GL.
    Cancer Res; 1993 Dec 01; 53(23):5802-7. PubMed ID: 8242639
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Correlation of frequency of induced mutation and metastatic potential in tumor cell lines from a single mouse mammary tumor.
    Yamashina K, Heppner GH.
    Cancer Res; 1985 Sep 01; 45(9):4015-9. PubMed ID: 4027998
    [Abstract] [Full Text] [Related]

  • 20. Systemic adoptive transfer of immunity to 13762A rat mammary adenocarcinoma.
    Boyer CM, Kreider JW, Bartlett GL.
    Cancer Res; 1981 Jun 01; 41(6):2394-400. PubMed ID: 6972251
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.